Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 6 min ago
PreprintCC BYmedRxiv

Vascular Remodelling in Idiopathic Nephrotic Syndrome with Administration of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

  1. 1Syiah Kuala University Faculty of Medicine: Universitas Syiah Kuala Fakultas Kedokteran

Abstract

Pediatric nephrotic syndrome (NS) significantly increases cardiovascular risk, primarily through activation of the renin-angiotensin-aldosterone system (RAAS) and chronic inflammation. This study aimed to evaluate the relationship between serum aldosterone and interleukin 6 (IL-6) levels with carotid intima-media thickness (CIMT) in children with steroid-sensitive (SSNS) and steroid-resistant NS (SRNS), before and after treatment with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB). This prospective, single-arm pretest-posttest study included 32 children aged 2-18 years with idiopathic NS at Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia. Participants received lisinopril and valsartan for 12 weeks. Serum aldosterone was quantified by liquid chromatography-tandem mass spectrometry, IL-6 by electrochemiluminescence immunoassay, and CIMT by high-resolution B-mode Doppler ultrasound. Data were analyzed using SPSS version 26.0, including Shapiro-Wilk normality testing, correlation analyses, and multivariate linear regression, with statistical significance set at p<0.05. CIMT decreased significantly after treatment (0.13{+/-}0.04 cm to 0.06{+/-}0.01 cm; p<0.001). Serum aldosterone and IL-6 did not change significantly. Multivariate regression identified steroid resistance as associated with CIMT change, while aldosterone and IL-6 showed no significant independent effects.

Related

  1. Angiotensin-Converting Enzyme in Patients With Early-Stage Psychosis
    Kun Yang, Luisa Longo, Pasquale Di Carlo +11
    JAMA PsychiatryPeer-reviewedLicence not statedFull text2 citedPsychiatry & mental healthPMC
  2. Case-control study on the association of angiotensin-converting enzyme gene I/D rs4646944 single nucleotide polymorphism and young-onset cryptogenic ischemic stroke in an Algerian cohort Estudo de caso-controle sobre associação do polimorfismo de nucleotídeo único I/D rs4646944 do gene da enzima conversora de angiotensina e acidente vascular isquêmico criptogênico de início precoce em coorte argelina
    Mohamed Lebsir, Mohamed Larbi Rezgoun, Boubekeur Saddik Fekraoui +4
    Jornal vascular brasileiroPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Glioblastoma model mouse rescue from mortality by brain-targeted catalytically-enhanced angiotensin-converting enzyme 2 mutant-antibody fusion protein
    P. Heinzelman, G. R. Nageeb, J. Choi +4
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  4. Deer antler tip cell culture supernatant restores endothelial barrier function and angiotensin converting enzyme 2/endothelial nitric oxide synthase nitric oxide signaling impaired by Porphyromonas gingivalis lipopolysaccharide.
    Ming-Shou Hsieh, Ya-Ting Yang, Chin-Sheng Huang +5
    Journal of dental sciencesPeer-reviewedCC BY-NC-NDFull textPhysiologyEurope PMC
  5. Plasma Angiotensin‐Converting Enzyme as a Prioritized Candidate Target for Alzheimer's Disease: Evidence From Proteome‐Wide Mendelian Randomization and a Large Prospective Cohort Study
    Peiyuan Huang, Haibo Tang, Zeying Feng +4
    Journal of the American Heart AssociationPeer-reviewedCC BYFull textPhysiologyCrossref
BibTeX
@misc{dimiati2026vascular,
  title = {{Vascular Remodelling in Idiopathic Nephrotic Syndrome with Administration of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers}},
  author = {H. Dimiati and S. Haris and K. Hasballah and S. Pardede},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.09.26365110},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.09.26365110v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Vascular Remodelling in Idiopathic Nephrotic Syndrome with Administration of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
AU  - H. Dimiati
AU  - S. Haris
AU  - K. Hasballah
AU  - S. Pardede
PY  - 2026
DA  - 2026/10/09
PB  - medRxiv
DO  - 10.64898/2026.10.09.26365110
UR  - https://www.medrxiv.org/content/10.64898/2026.10.09.26365110v1
AB  - Pediatric nephrotic syndrome (NS) significantly increases cardiovascular risk, primarily through activation of the renin-angiotensin-aldosterone system (RAAS) and chronic inflammation. This study aimed to evaluate the relationship between serum aldosterone and interleukin 6 (IL-6) levels with carotid intima-media thickness (CIMT) in children with steroid-sensitive (SSNS) and steroid-resistant NS (SRNS), before and after treatment with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB). This prospective, single-arm pretest-posttest study included 32 children aged 2-18 years with idiopathic NS at Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia. Participants received lisinopril and valsartan for 12 weeks. Serum aldosterone was quantified by liquid chromatography-tandem mass spectrometry, IL-6 by electrochemiluminescence immunoassay, and CIMT by high-resolution B-mode Doppler ultrasound. Data were analyzed using SPSS version 26.0, including Shapiro-Wilk normality testing, correlation analyses, and multivariate linear regression, with statistical significance set at p<0.05. CIMT decreased significantly after treatment (0.13{+/-}0.04 cm to 0.06{+/-}0.01 cm; p<0.001). Serum aldosterone and IL-6 did not change significantly. Multivariate regression identified steroid resistance as associated with CIMT change, while aldosterone and IL-6 showed no significant independent effects.
ER  -